Matches in Nanopublications for { ?s ?p "[Our collective observations provide evidence that a small molecule inhibitor targeted to the FAK protein-protein interaction site successfully inhibits melanoma growth through dual targeting of tumor and endothelial cells and is effective against both BRAF wild type and mutant melanomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[Our collective observations provide evidence that a small molecule inhibitor targeted to the FAK protein-protein interaction site successfully inhibits melanoma growth through dual targeting of tumor and endothelial cells and is effective against both BRAF wild type and mutant melanomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Our collective observations provide evidence that a small molecule inhibitor targeted to the FAK protein-protein interaction site successfully inhibits melanoma growth through dual targeting of tumor and endothelial cells and is effective against both BRAF wild type and mutant melanomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1246021.RAPiE1IIbZbfP2o4dHwSPSy2OF5UPDD04a-QDEmUCVP4E130_assertion description "[Our collective observations provide evidence that a small molecule inhibitor targeted to the FAK protein-protein interaction site successfully inhibits melanoma growth through dual targeting of tumor and endothelial cells and is effective against both BRAF wild type and mutant melanomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246021.RAPiE1IIbZbfP2o4dHwSPSy2OF5UPDD04a-QDEmUCVP4E130_provenance.
- NP1246020.RAzQBakHSD3MdA3toDgjQsJfaJDEp9RdGmqCrjk0wGr_w130_assertion description "[Our collective observations provide evidence that a small molecule inhibitor targeted to the FAK protein-protein interaction site successfully inhibits melanoma growth through dual targeting of tumor and endothelial cells and is effective against both BRAF wild type and mutant melanomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246020.RAzQBakHSD3MdA3toDgjQsJfaJDEp9RdGmqCrjk0wGr_w130_provenance.